HEADER ANTIMICROBIAL PROTEIN 07-JUL-21 7RC7 TITLE SOLUTION NMR STRUCTURE OF [ALA19]CRP4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-DEFENSIN 4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DEFENSIN-RELATED CRYPTDIN-4; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 4 ORGANISM_COMMON: MOUSE; SOURCE 5 ORGANISM_TAXID: 10090 KEYWDS CRYPTDIN, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR A.C.CONIBEAR,K.J.ROSENGREN REVDAT 3 14-JUN-23 7RC7 1 REMARK REVDAT 2 23-FEB-22 7RC7 1 JRNL REVDAT 1 11-AUG-21 7RC7 0 JRNL AUTH R.J.CLARK,T.H.PHAN,A.SONG,A.J.OUELLETTE,A.C.CONIBEAR, JRNL AUTH 2 K.J.ROSENGREN JRNL TITL A CONSERVED BETA-BULGE GLYCINE RESIDUE FACILITATES FOLDING JRNL TITL 2 AND INCREASES STABILITY OF THE MOUSE ALPHA-DEFENSIN JRNL TITL 3 CRYPTDIN-4 JRNL REF PEPTIDE SCIENCE V. 114 2022 JRNL REFN ISSN 1344-7661 JRNL DOI 10.1002/PEP2.24250 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA, CNS, CNS REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ (CNS), REMARK 3 BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USING TORSION ANGLE DYNAMICS REMARK 4 REMARK 4 7RC7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1000257636. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 4 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MG/ML [ALA19]CRP4, 1 MM DSS, REMARK 210 90% H2O/10% D2O; 1 MG/ML [ALA19] REMARK 210 CRP4, 1 MM DSS, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1D; 2D 1H-1H TOCSY; 2D 1H-1H REMARK 210 NOESY; 2D 1H-13C HSQC; 2D 1H-15N REMARK 210 HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA, TOPSPIN REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 ALA A 19 -176.91 -172.43 REMARK 500 4 ALA A 19 -176.67 -173.68 REMARK 500 9 ILE A 23 -61.05 -105.44 REMARK 500 12 ALA A 19 -175.89 -177.14 REMARK 500 15 ALA A 19 -176.99 -178.00 REMARK 500 16 ALA A 19 -176.29 -171.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30933 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF [ALA19]CRP4 DBREF 7RC7 A 1 32 UNP P28311 DEFA4_MOUSE 61 92 SEQADV 7RC7 ALA A 19 UNP P28311 GLY 79 ENGINEERED MUTATION SEQRES 1 A 32 GLY LEU LEU CYS TYR CYS ARG LYS GLY HIS CYS LYS ARG SEQRES 2 A 32 GLY GLU ARG VAL ARG ALA THR CYS GLY ILE ARG PHE LEU SEQRES 3 A 32 TYR CYS CYS PRO ARG ARG SHEET 1 AA1 3 TYR A 5 LYS A 8 0 SHEET 2 AA1 3 PHE A 25 PRO A 30 -1 O CYS A 28 N TYR A 5 SHEET 3 AA1 3 GLU A 15 THR A 20 -1 N ARG A 16 O CYS A 29 SSBOND 1 CYS A 4 CYS A 29 1555 1555 2.03 SSBOND 2 CYS A 6 CYS A 21 1555 1555 2.02 SSBOND 3 CYS A 11 CYS A 28 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1